Showing results (281-290 of 391) with videos related to
Sort By:
Pageof 40
Oncoimmunology|July 9, 2021
Cisplatin inhibits frequency and suppressive activity of monocytic myeloid-derived suppressor cells in cancer patientsGlenn F Van Wigcheren, Nienke De Haas, Tom A Mulder, et al.British Journal of Cancer|September 16, 2010
Short-term health-related quality of life and symptom control with docetaxel, cisplatin, 5-fluorouracil and cisplatin (TPF), 5-fluorouracil (PF) for induction in unresectable locoregionally advanced head and neck cancer patients (EORTC 24971/TAX 323)C M L van Herpen, M E Mauer, R Mesia, et al.Cancer|March 22, 2012
Pemetrexed in combination with cisplatin versus cisplatin monotherapy in patients with recurrent or metastatic head and neck cancer: final results of a randomized, double-blind, placebo-controlled, phase 3 studySusan Urba, Carla M L van Herpen, Tarini Prasad Sahoo, et al.BMC Cancer|March 26, 2014
Impairment of cognitive functioning during Sunitinib or Sorafenib treatment in cancer patients: a cross sectional studySasja F Mulder, Dirk Bertens, Ingrid M E Desar, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2005
Intratumoral recombinant human interleukin-12 administration in head and neck squamous cell carcinoma patients modifies locoregional lymph node architecture and induces natural killer cell infiltration in the primary tumorCarla M L van Herpen, Jeroen A W M van der Laak, I Jolanda M de Vries, et al.European Journal of Cancer (Oxford, England : 1990)|February 28, 2012
Modest improvement in 20 years of kidney cancer care in the NetherlandsSaskia A M van de Schans, Katja K H Aben, Peter F A Mulders, et al.Head & Neck|June 8, 2019
Prevalence and clinical and psychological correlates of high fear of cancer recurrence in patients newly diagnosed with head and neck cancerSpela Mirosevic, Belinda Thewes, Carla van Herpen, et al.Head & Neck|August 22, 2012
Aggressive fibromatosis in the head and neck region: Benign tumor with often mutilating effectsMathijs P Hendriks, Chantal M L Driessen, Hanneke W M van Laarhoven, et al.Theranostics|September 23, 2024
Lutetium-177-PSMA therapy for recurrent/metastatic salivary gland cancer: a prospective pilot studyNiels J van Ruitenbeek, Maike J M Uijen, Chantal M L Driessen, et al.Annals of Botany|July 16, 2008
Detailed analysis of the expression of an alpha-gliadin promoter and the deposition of alpha-gliadin protein during wheat grain developmentT W J M Van Herpen, M Riley, C Sparks, et al.Pageof 40